Treace Medical Concepts (TMCI) FCF Margin (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly FCF Margin came in at 15.2% in Q2 2026, up 129.0% on a YoY basis from 6.64% in Q2 2025, and down 271.76% quarter-over-quarter from 8.85% in Q1 2026.
Powered by 
Analysis
Treace Medical Concepts (TMCI) FCF Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has reported FCF Margin for 7 consecutive years, with 15.2% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin rose 129.0% year-over-year to 15.2%; the trailing twelve-month figure through Jun 2026 stood at 12.2% (up 144.0% YoY), and the FY2025 full-year result was 13.86%, up 943.0% from the prior year.
- FCF Margin retreated to 15.2% in Q2 2026 per TMCI's latest filing, from 8.85% in the prior quarter.
- Across five years, FCF Margin topped out at 8.85% in Q1 2026 and bottomed at 52.5% in Q2 2022.
- Historically, FCF Margin has averaged 22.75% across 5 years, with a median of 22.76% in 2024.
- The sharpest annual moves came in 2022 and 2025: FCF Margin slumped 3108 bps in 2022, then surged 2306 bps in 2025.
- Over 5 years, FCF Margin stood at 15.43% in 2022, then soared by 82 bps to 2.76% in 2023, then slumped by 284 bps to 10.6% in 2024, then tumbled by 57 bps to 16.67% in 2025, then climbed by 9 bps to 15.2% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 15.2%, 8.85%, and 16.67% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 18.73% |
| 10 | Treace Medical Concepts | 312.82 Mn | 267.20 Mn | 35.61 Mn | -15.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.20% |
| Mar 31, 2026 | 8.85% |
| Dec 31, 2025 | -16.67% |
| Sep 30, 2025 | -23.70% |
| Jun 30, 2025 | -16.50% |
| Mar 31, 2025 | 1.25% |
| Dec 31, 2024 | -10.60% |
| Sep 30, 2024 | -32.62% |
| Jun 30, 2024 | -35.15% |
| Mar 31, 2024 | -21.81% |
| Dec 31, 2023 | -2.76% |
| Sep 30, 2023 | -31.93% |
| Jun 30, 2023 | -29.95% |
| Mar 31, 2023 | -44.41% |
| Dec 31, 2022 | -15.43% |
| Sep 30, 2022 | -40.39% |
| Jun 30, 2022 | -52.50% |
| Mar 31, 2022 | -30.03% |
| Dec 31, 2021 | -13.91% |
| Sep 30, 2021 | -47.09% |